Evaluating ambroxol as an agent to boost lysosomal function and reduce beta amyloid in 3xTg mice
Our findings demonstrate that ambroxol is able to reduce intracellular accumulation of Aβ by upregulating lysosomal activity, and therefore may be a promising treatment for AD.
Authors
- Shyam Gajavelli (ORCID: https://orcid.org/0000-0002-5947-6973)
- Adrianna R Tsang
- Stephen Pasternak (ORCID: https://orcid.org/0000-0002-0204-0255)
- Lynn Wang (ORCID: https://orcid.org/0000-0002-6230-3803)
Institutions
- Western University (CA)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.093495
- Primary Topic
- Neuroscience and Neuropharmacology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00